Siflon Drugs Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2010.
2010 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Siflon Drugs Private Limited

Siflon Drugs Private Limited, a active private limited company, was established on 19 March 2010 in Hyderabad, Telangana, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24232TG2010PTC067606. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹6.15 Cr and a paid-up capital of ₹6.15 Cr.

It upholds a active non-compliant status. Employing 46 professional, Its leadership includes Ananthaiah Rallapalli (Managing Director), Parvathi Rallapalli (Director), Swetha Rallapalli (Director). It holds ₹33.61 Cr open charges and ₹4.96 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.76 & 77, Manu Residency Mathri Nagar, Miyapur, Hyderabad, Telangana, 500050.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2010PTC067606

  • Registration Number

    067606

  • Incorporation Date

    19 March 2010

  • Authorized Capital

    ₹6.15 Cr

  • Paid-Up Capital

    ₹6.15 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.15 Cr
  • Paid Up Capital ₹ 6.15 Cr
  • Company Age 15 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 33.61 Cr
  • Satisfied Charges ₹ 4.96 Cr
  • Revenue Growth **** 68399.27%
  • Profit Growth **** -512641.11%
  • Ebitda **** -1009714.49%
  • Net Worth 15249.56%
  • Total Assets **** 99587.66%
Company report

Siflon Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Siflon Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Siflon Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Ananthaiah Rallapalli Managing Director 19 Mar 2010 Current
Parvathi Rallapalli Director 19 Mar 2010 Current
Swetha Rallapalli Director 19 Mar 2010 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Siflon Drugs.

Siflon Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 68399.27% increase. The company also saw a substantial fall in profitability, with a 512641.11% decrease in profit. The company's net worth Soared by an impressive increase of 15249.56%.

Siflon Drugs revenue growth over time
Siflon Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 68399.27%
*******
*******
*******
*******
Revenue from Operations
*******
 68326.59%
*******
*******
*******
*******
Total Assets
*******
 99587.66%
*******
*******
*******
*******
Profit or Loss
*******
 -512641.11%
*******
*******
*******
*******
Net Worth
*******
 15249.56%
*******
*******
*******
*******
EBITDA
*******
 -1009714.49%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Siflon Drugs?

In 2023, Siflon Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹336,100,000.00

Satisfied Charges

₹49,550,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 33.61 Cr
Latest Charge Details
Date Lender Amount Status
22 Mar 2019 Axis Bank Limited ₹6.83 Cr Open
30 Jul 2015 Axis Bank Limited ₹25.00 Cr Open
30 Jul 2015 Axis Bank Limited ₹1.78 Cr Open
09 May 2011 Oriental Bank Of Commerce ₹4.96 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Siflon Drugs?

Siflon Drugs has a workforce of 46 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Siflon Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siflon Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Siflon Drugs
Recent Activity within the Organization
  • Charges

    Progress on A charge with Axis Bank Limited of Rs. 6.83 Cr registered on 22 Mar 2019 with Charge ID 100254464 was modified on 27 Jan 2025. was documented.

  • Annual General Meeting

    Siflon Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Siflon Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 1.78 Cr registered on 30 Jul 2015 with Charge ID 10588407 was modified on 29 Jul 2020. was completed.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 6.83 Cr with Charge ID 100254464 was registered on 22 Mar 2019. was documented.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 25.00 Cr registered on 30 Jul 2015 with Charge ID 10588447 was modified on 08 Mar 2018. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Siflon Drugs Private Limited?

The CIN of Siflon Drugs Private Limited is U24232TG2010PTC067606.

Where is Siflon Drugs Private Limited headquartered?

Siflon Drugs Private Limited is headquartered at Plot No.76 & 77, Manu Residency Mathri Nagar, Miyapur, Hyderabad, Telangana, 500050.

When was Siflon Drugs Private Limited incorporated?

Siflon Drugs Private Limited was incorporated on 19 March 2010.

Who are the current directors of Siflon Drugs Private Limited?

The current directors of Siflon Drugs Private Limited are

What is the primary industry of Siflon Drugs Private Limited?

The primary industry of Siflon Drugs Private Limited is Manufacturing.

Is Siflon Drugs Private Limited a listed company?

Siflon Drugs Private Limited is unlisted.

What is the capital structure of Siflon Drugs Private Limited?

The authorized capital of Siflon Drugs Private Limited is ₹6.15 Cr, and the paid-up capital is ₹6.15 Cr.

What is the compliance status of Siflon Drugs Private Limited?

The compliance status of Siflon Drugs Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available